FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Healthcare Global IPO is a book built issue of Rs 649.64 crores.
Healthcare Global IPO bidding started from March 16, 2016 and ended on March 18, 2016. The shares got listed on BSE, NSE on March 30, 2016.
Healthcare Global IPO price band is set at ₹205 to ₹218 per share. The minimum lot size for an application is 65 Shares. The minimum amount of investment required by retail investors is ₹14,170.
Edelweiss Financial Services Ltd, Goldman Sachs (India) Securities Private Limited, Dam Capital Advisors Ltd (Formerly Idfc Securities Ltd), Iifl Securities Ltd, Kotak Mahindra Capital Company Limited and Yes Bank Limited are the book running lead managers of the Healthcare Global IPO, while Kfin Technologies Limited is the registrar for the issue.
Refer to Healthcare Global IPO RHP for detailed information.
| IPO Date | March 16, 2016 to March 18, 2016 |
| Listing Date | March 30, 2016 |
| Face Value | ₹10 per share |
| Price Band | ₹205 to ₹218 per share |
| Lot Size | 65 Shares |
| Total Issue Size | 29,800,000 shares (aggregating up to ₹649.64 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
Healthcare Global IPO a total of 16,390,000 shares are offered. QIB: 8,940,000 (54.55%), RII: 2,980,000 (18.18%), NII: 4,470,000 (27.27%).
| Anchor Investor Shares Offered | - |
| QIB Shares Offered | 8,940,000 (54.55%) |
| NII (HNI) Shares Offered | 4,470,000 (27.27%) |
| Retail Shares Offered | 2,980,000 (18.18%) |
| Total Shares Offered | 16,390,000 (100%) |
Investors can bid for a minimum of 65 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 65 | ₹14,170 |
| Retail (Max) | 14 | 910 | ₹198,380 |
| Lot Size Calculator | |||
Healthcare Global Enterprises Ltd (HCG) is Bangalore India based provider of speciality healthcare in India focused on cancer and fertility.
HCG operates the largest cancer care network in India in terms of the total number of private cancer treatment centres licensed. HCG also operates fertility centres under the 'Milann' brand.
As of December 31, 2015, HCG network consisted of 14 comprehensive cancer centres, including centre of excellence in Bengaluru, three freestanding diagnostic centres and one day care chemotherapy centre across India.
HCG acquired 50.10% equity in BACC Healthcare in 2013 which operates fertility centres under the Milann brand, through itself and its wholly-owned subsidiary, DKR Healthcare. HCG now operate four Milann fertility centres in Bengaluru. BACC Healthcare is led by a team of qualified and experienced fertility specialists. Its founder, Dr. Kamini Rao has a successful track record of over 25 years of providing fertility treatments. Milann fertility centres provide comprehensive reproductive medicine services, including assisted reproduction, gynaecological endoscopy and fertility preservation; and follow a multidisciplinary and technology-focused approach to diagnosis and treatment.
Under Triesta brand, HCG provide clinical reference laboratory services in India with a specialisation in oncology, including molecular diagnostic services and genomic testing. Triesta central reference laboratory is located in centre of excellence in Bengaluru.
Strengths of the Company:
1. Largest provider of cancer care in India with a proven track record
2. High quality cancer care provided at a competitive price
3. Entry into high potential fertility business
4. Strong management team with successful track record
5. Highly skilled specialist physicians
6. 'hub and spoke' business model and partnership arrangements
|
Particulars |
For the year/period ended (in Rs. Million) | ||||
| � | 31-Mar-15 | 31-Mar-14 | 31-Mar-13 | 31-Mar-12 | 31-Mar-11 |
| Total Liabilities | 6,895.42 | 6,138.21 | 6,436.40 | 4,362.63 | 3,203.63 |
| Total Assets | 6,895.42 | 6,138.21 | 6,436.40 | 4,362.63 | 3,203.63 |
| Total Revenue | 4,244.41 | 3,525.94 | 2,939.52 | 2,051.67 | 1,601.43 |
| Profit After Tax (PAT) | (23.66) | (394.98) | (71.58) | (40.02) | 34.40 |
The Offer comprises of Fresh Issue and the Offer for Sale.
Offer for Sale
Company will not receive any proceeds from the Offer for Sale.
Fresh Issue
Company proposes to utilise the Net Proceeds towards funding the following objects:
1. Purchase of medical equipment;
2. Investment in IT software, services and hardware;
3. Pre-payment of debt; and
4. General corporate purposes.
[Dilip Davda]
Although the company’s performance has been in negative zone, unique model of Cancer and Fertility treatment under HCG and Milann brands are expected to generate positive earnings in next two to three years. Long term investors may consider investment for adding value on their investment.
Read detail review...The Healthcare Global IPO is subscribed 1.56 times on Mar 18, 2016 1:00:00 PM. The public issue subscribed 0.83 times in the retail category, 2.36 times in the QIB category, and 0.43 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) |
|---|---|
| QIB | 2.36 |
| NII | 0.43 |
| Retail | 0.83 |
| Total | 1.56 |
| Listing Date | March 30, 2016 |
| BSE Script Code | 539787 |
| NSE Symbol | HCG |
| ISIN | INE075I01017 |
| Final Issue Price | ₹218 per share |
| Price Details |
|---|
| Final Issue Price |
| Open |
| Low |
| High |
| Last Trade |
| BSE |
|---|
| ₹218.00 |
| ₹209.80 |
| ₹169.00 |
| ₹211.00 |
| ₹170.95 |
| NSE |
|---|
| ₹218.00 |
| ₹210.20 |
| ₹169.10 |
| ₹211.90 |
| ₹171.00 |
Healthcare Global Enterprises Ltd
HCG Tower, No. 8, P Kalinga Rao Road,
Sampangi Rama Nagar,
Bengaluru 560 027
Phone: +91 80 4660 7700
Email: investors@hcgoncology.com
Website: http://www.hcgel.com
Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: einward.ris@karvy.com
Website: https://kosmic.kfintech.com/ipostatus/
Lead Manager Reports
Healthcare Global IPO is a main-board IPO of 29,800,000 equity shares of the face value of ₹10 aggregating up to ₹649.64 Crores. The issue is priced at ₹205 to ₹218 per share. The minimum order quantity is 65 Shares.
The IPO opens on March 16, 2016, and closes on March 18, 2016.
Kfin Technologies Limited is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
The Healthcare Global IPO opens on March 16, 2016 and closes on March 18, 2016.
Healthcare Global IPO lot size is 65 Shares, and the minimum amount required is ₹14,170.
You can apply in Healthcare Global IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Nuvama, ICICI Bank, HDFC Bank and SBI Bank.
The finalization of Basis of Allotment for Healthcare Global IPO will be done on [.], and the allotted shares will be credited to your demat account by [.]. Check the Healthcare Global IPO allotment status.
IPO Mentor (1000+ Posts, 400+ Likes)
Useful Articles
FREE Account Opening (₹0)
FREE Intraday Trading (Eq, F&O)
|
|
RHP
Top Contributor (200+ Posts, 100+ Likes)
